Single-use Bioprocessing Material Market Size, Share & Trends Analysis Report By Product (Plastic, Silicone, Other), By Applications (Biopharmaceutical Manufacturers, Life Science R&D and Academic Research Institutes, Contract Research Organization & Manufacturers, Others), By End Use, By Region, and Segment Forecasts - 2035

Single-use Bioprocessing Material Market Overview

single-use bioprocessing material market Size was estimated at 4216.63 USD million in 2025, The industry is projected to grow from 4663.59 USD million in 2026 to 11907.31 USD million by 2035, exhibiting a compound annual growth rate (CAGR) of 10.6% during the forecast period 2026 - 2035.

The Single-use Bioprocessing Material Market has expanded significantly with over 75% of biopharmaceutical manufacturers integrating single-use systems in upstream or downstream processes as of 2024. More than 12,000 bioprocessing facilities globally utilize disposable bags, filters, and tubing assemblies, with over 65% of new biologics manufacturing lines designed as single-use facilities. Approximately 40% of global monoclonal antibody production capacity under 2,000 liters relies on single-use bioprocessing materials. Over 55% of vaccine production facilities implemented single-use assemblies post-2020. The Single-use Bioprocessing Material Market Report indicates that more than 70% of clinical-scale biologics manufacturing now depends on disposable materials for contamination control and faster turnaround cycles.

In the United States, over 60% of biologics manufacturing facilities use single-use bioprocessing materials for at least one production stage. The U.S. accounts for approximately 35% of global installed single-use bioreactor capacity under 2,000 liters. More than 500 FDA-registered biologics facilities operate with single-use components integrated into purification and filtration lines. Around 80% of U.S.-based CDMOs use disposable tubing and bag assemblies in pilot-scale operations. The Single-use Bioprocessing Material Market Analysis shows that over 45% of newly approved biologics between 2021 and 2024 were produced in facilities incorporating single-use technologies.

• 

  Download Free sample to learn more about this report.

Key Findings

• Key Market Driver:Over 75% adoption in clinical biologics manufacturing, 68% contamination reduction rates, 50% reduction in cleaning validation time, 60% faster batch changeover, 72% implementation in vaccine production, and 65% preference among CDMOs for flexible manufacturing.
• Major Market Restraint:35% supply chain disruption impact, 28% raw material dependency risk, 32% extractables and leachables concerns, 25% waste disposal limitations, 30% high import reliance for polymer resins, and 22% regulatory compliance delays.
• Emerging Trends:55% growth in single-use sensors integration, 48% expansion in hybrid stainless-steel systems, 63% increase in modular facility adoption, 52% automation compatibility rate, 58% uptake in mRNA production, and 47% digital monitoring implementation.
• Regional Leadership:North America holds 38% market share, Europe accounts for 30%, Asia-Pacific represents 24%, Middle East & Africa contribute 5%, and Latin America captures 3% of total global deployment.
• Competitive Landscape:Top 5 manufacturers control 62% market share, top 2 companies hold 38%, 45% of suppliers focus on filtration products, 33% specialize in bag assemblies, and 27% invest in automation-compatible disposables.
• Market Segmentation:Plastic materials represent 64% share, silicone accounts for 21%, other materials contribute 15%; biopharmaceutical manufacturers hold 58% demand share, CROs 22%, research institutes 14%, others 6%.
• Recent Development:48% increase in capacity expansion projects in 2023–2024, 35% rise in automation-ready product launches, 40% growth in sterile connector innovation, 29% sustainability-focused product upgrades, and 33% expansion in Asia-Pacific facilities.

Single-use Bioprocessing Material Market Latest Trends

The Single-use Bioprocessing Material Market Trends indicate that over 63% of newly constructed biologics plants under 2,000-liter capacity are fully disposable-based facilities. Approximately 58% of mRNA and cell therapy manufacturing lines installed after 2021 rely on single-use bags and tubing assemblies. Around 46% of manufacturers report a 30% reduction in cross-contamination incidents after shifting to disposable flow paths. The Single-use Bioprocessing Material Market Research Report highlights that over 52% of companies have integrated real-time monitoring sensors into disposable bioreactor systems.

Hybrid systems combining stainless steel and single-use components account for nearly 42% of large-scale facilities above 2,000 liters. More than 55% of filtration steps in downstream processing now use disposable membrane filters. Sustainability initiatives have increased polymer recycling initiatives by 18% between 2022 and 2024. The Single-use Bioprocessing Material Market Outlook shows that over 70% of CDMOs prefer single-use platforms for multi-product facilities handling more than 5 biologics annually.

Single-use Bioprocessing Material Market Dynamics

DRIVER

Rising demand for biologics and advanced therapies

Over 50% of new drug approvals between 2021 and 2024 were biologics, increasing dependency on flexible manufacturing systems. More than 65% of monoclonal antibody production facilities operate under 2,000-liter scale, favoring single-use systems. Approximately 72% of vaccine facilities implemented disposable bioprocessing assemblies after 2020. Around 60% of cell and gene therapy production sites rely exclusively on single-use platforms. The Single-use Bioprocessing Material Market Growth is strongly driven by 45% shorter facility construction timelines and 35% lower validation cycles compared to traditional systems.

RESTRAINT

Waste management and material disposal concerns

Single-use systems generate approximately 3–5 kg of plastic waste per 1,000-liter batch. Nearly 40% of manufacturers report challenges in recycling multi-layer polymer films. Around 28% of regulatory inspections focus on extractables and leachables data validation. Approximately 30% of raw materials are sourced from limited global polymer suppliers. The Single-use Bioprocessing Material Industry Analysis shows that 22% of manufacturers face import-related delays exceeding 4 weeks.

OPPORTUNITY

Expansion in emerging markets biomanufacturing

Asia-Pacific has increased biologics manufacturing facilities by 35% between 2021 and 2024. Nearly 48% of new facilities in India, China, and South Korea adopt single-use systems. Government-supported biotech parks in over 12 countries have integrated disposable production lines. Approximately 55% of new CDMO facilities in Southeast Asia use modular single-use setups. The Single-use Bioprocessing Material Market Opportunities are strengthened by 60% faster deployment of prefabricated facilities.

CHALLENGE

Supply chain volatility and standardization gaps

During 2020–2022, 38% of manufacturers experienced delays exceeding 6 weeks in obtaining disposable bags and filters. Over 25% reported inconsistencies in tubing compatibility across suppliers. Approximately 31% of companies require dual-supplier qualification strategies. Around 27% face batch-to-batch variability testing requirements. The Single-use Bioprocessing Material Market Forecast identifies standardization challenges across more than 20 regulatory jurisdictions.

• 

  Download Free sample to learn more about this report.

Segmentation Analysis

The Single-use Bioprocessing Material Market Size is segmented by type and application, with plastics accounting for 64% share, silicone 21%, and other materials 15%. By application, biopharmaceutical manufacturers contribute 58% demand, CROs 22%, research institutes 14%, and others 6%. Over 70% of disposable bags are plastic-based, while 80% of sterile connectors use polymer composites.

By Type

Plastic:Plastic materials account for approximately 64% of the Single-use Bioprocessing Material Market Share. Over 75% of disposable bioreactor bags are multi-layer polyethylene-based. Nearly 68% of tubing assemblies use thermoplastic elastomers. Around 50% of filtration membranes incorporate polypropylene. Plastic-based systems reduce cleaning cycles by 60% and lower contamination risks by 45%.

Silicone:Silicone materials represent 21% market share and are used in 55% of high-flexibility tubing applications. Approximately 48% of peristaltic pump tubing utilizes platinum-cured silicone. Silicone withstands temperatures up to 200°C in sterilization processes. Around 35% of advanced cell therapy systems require silicone connectors for flexibility and chemical resistance.

Other:Other materials contribute 15% share, including fluoropolymers and polycarbonate components. Nearly 30% of sterile connectors use specialized composite polymers. Around 25% of high-pressure filtration capsules rely on polycarbonate housings. These materials provide 40% higher chemical resistance compared to standard plastics.

By Application

Biopharmaceutical Manufacturers:Biopharmaceutical manufacturers account for 58% demand. Over 70% of monoclonal antibody production lines integrate disposable bags. Approximately 65% of vaccine production lines utilize single-use filters. Around 50% of upstream fermentation steps rely on disposable bioreactors under 2,000 liters.

Life Science R&D and Academic Research Institutes:Research institutes represent 14% demand. Nearly 60% of university bioprocess labs use single-use systems. Around 45% of pilot-scale experiments adopt disposable filtration units. Over 30% of translational research centers prefer modular single-use platforms.

Contract Research Organization & Manufacturers:CROs and CDMOs account for 22% demand. Approximately 80% of CDMOs utilize disposable assemblies for multi-product manufacturing. Around 55% of clinical trial batches use single-use upstream systems. Nearly 48% report 25% faster changeover times.

Others:Other applications contribute 6%, including diagnostic manufacturers and veterinary biologics producers. Nearly 35% of diagnostic reagent facilities use disposable mixing systems. Around 20% of veterinary vaccine facilities utilize single-use purification assemblies.

• 

  Download Free sampleto learn more about this report.

Regional Outlook

• North America holds 38% share with over 500 operational biologics facilities.
• Europe accounts for 30% share with more than 350 GMP-certified biologics sites.
• Asia-Pacific represents 24% share with 200+ expanding biomanufacturing plants.
• Middle East & Africa hold 5% share with 40+ emerging biotech hubs.

North America

North America commands 38% of the Single-use Bioprocessing Material Market Share. The U.S. operates over 500 biologics manufacturing sites, with 60% integrating disposable systems. Canada contributes 8% regional share with 40+ GMP biologics facilities. Around 75% of CDMOs in the region deploy single-use upstream systems. More than 50% of clinical-scale production relies on disposable filtration units.

Europe

Europe accounts for 30% share with Germany, France, and the UK representing over 65% of regional demand. Approximately 55% of European biologics facilities under 2,000 liters utilize disposable bioreactors. Over 40% of vaccine production facilities transitioned to hybrid systems between 2021 and 2024. Nearly 48% of EU-funded biotech infrastructure projects incorporate single-use platforms.

Asia-Pacific

Asia-Pacific represents 24% share, with China and India contributing 60% of regional installations. Over 35% increase in biologics facilities occurred between 2021 and 2024. Approximately 48% of new facilities adopt single-use systems. South Korea operates over 25 large biologics plants, with 50% utilizing disposable upstream technologies.

Middle East & Africa

Middle East & Africa hold 5% share, with over 40 emerging biotech hubs. Approximately 30% of new facilities in the UAE and Saudi Arabia integrate single-use platforms. Around 25% of vaccine production facilities in Africa utilize disposable filtration units. Nearly 18% increase in regional biotech investments occurred between 2022 and 2024.

List of Top Single-use Bioprocessing Material Companies

• Thermo Fisher Scientific (US)
• Sartorius Stedim Biotech S.A (France)
•  

These 2 companies collectively hold approximately 38% of global Single-use Bioprocessing Material Market Share, with Thermo Fisher accounting for around 22% and Sartorius holding nearly 16%. Both operate in over 30 countries and maintain more than 15 manufacturing sites each dedicated to disposable systems.

Investment Analysis and Opportunities

Over 48% of biologics manufacturers increased capital allocation toward single-use capacity expansion between 2022 and 2024. Approximately 35% of new greenfield facilities utilize modular single-use configurations. Venture investments in cell and gene therapy infrastructure increased by 28% during 2023. Nearly 60% of CDMOs expanded disposable assembly production lines. Asia-Pacific attracted 32% of new facility investments globally. The Single-use Bioprocessing Material Market Opportunities include 45% reduction in facility build timelines and 30% improvement in operational flexibility. Government-backed biotech initiatives in over 15 countries support disposable manufacturing infrastructure.

New Product Development

Between 2023 and 2025, over 35% of new product launches focused on automation-compatible disposable sensors. Approximately 40% of sterile connector innovations enhanced leak-proof assurance by 25%. Nearly 30% of new bioreactor bag models improved oxygen transfer rates by 18%. Around 22% of manufacturers introduced recyclable polymer blends. Over 50% of next-generation filtration capsules extended throughput capacity by 15%. The Single-use Bioprocessing Material Market Trends emphasize integration of digital monitoring modules in 45% of new system releases.

Five Recent Developments (2023–2025)

1. In 2023, a leading manufacturer expanded single-use production capacity by 30% across 2 facilities.
2. In 2024, a global supplier launched 15 new disposable sensor models with 20% enhanced accuracy.
3. In 2024, a company invested in a 40,000-square-foot facility dedicated to filtration assemblies.
4. In 2025, a manufacturer introduced recyclable bag systems reducing polymer waste by 18%.
5. Between 2023 and 2025, 3 major players expanded Asia-Pacific operations by 25%.

Report Coverage of Single-use Bioprocessing Material Market

The Single-use Bioprocessing Material Market Report covers over 20 countries, analyzing more than 50 manufacturers and 4 primary material types. The report evaluates 10-year installation data across 500+ facilities globally. It includes segmentation by 3 material categories and 4 application sectors, representing 100% of market demand distribution. Regional analysis spans North America (38%), Europe (30%), Asia-Pacific (24%), and Middle East & Africa (5%). The Single-use Bioprocessing Material Market Research Report provides insights into 25 regulatory frameworks and assesses over 40 recent product innovations between 2023 and 2025.